174 related articles for article (PubMed ID: 32336148)
1. Composite active range of motion (CX
Bayle N; Maisonobe P; Raymond R; Balcaitiene J; Gracies JM
Clin Rehabil; 2020 Jun; 34(6):803-811. PubMed ID: 32336148
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.
Gracies JM; Esquenazi A; Brashear A; Banach M; Kocer S; Jech R; Khatkova S; Benetin J; Vecchio M; McAllister P; Ilkowski J; Ochudlo S; Catus F; Grandoulier AS; Vilain C; Picaut P;
Neurology; 2017 Nov; 89(22):2245-2253. PubMed ID: 29093068
[TBL] [Abstract][Full Text] [Related]
4. Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
McAllister PJ; Khatkova SE; Faux SG; Picaut P; Raymond R; Gracies JM
J Rehabil Med; 2019 Oct; 51(10):813-816. PubMed ID: 31529136
[TBL] [Abstract][Full Text] [Related]
5. Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
O'Dell MW; Brashear A; Jech R; Lejeune T; Marque P; Bensmail D; Ayyoub Z; Simpson DM; Volteau M; Vilain C; Picaut P; Gracies JM
PM R; 2018 Jan; 10(1):1-10. PubMed ID: 28634000
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of AbobotulinumtoxinA (Dysport) for the Treatment of Hemiparesis in Adults With Upper Limb Spasticity Previously Treated With Botulinum Toxin: Subanalysis From a Phase 3 Randomized Controlled Trial.
Marciniak C; McAllister P; Walker H; Brashear A; Edgley S; Deltombe T; Khatkova S; Banach M; Gul F; Vilain C; Picaut P; Grandoulier AS; Gracies JM;
PM R; 2017 Dec; 9(12):1181-1190. PubMed ID: 28625615
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.
Gracies JM; O'Dell M; Vecchio M; Hedera P; Kocer S; Rudzinska-Bar M; Rubin B; Timerbaeva SL; Lusakowska A; Boyer FC; Grandoulier AS; Vilain C; Picaut P;
Muscle Nerve; 2018 Feb; 57(2):245-254. PubMed ID: 28590525
[TBL] [Abstract][Full Text] [Related]
8. Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
Gracies JM; Francisco GE; Jech R; Khatkova S; Rios CD; Maisonobe P;
J Neurol Phys Ther; 2021 Jul; 45(3):203-213. PubMed ID: 34039905
[TBL] [Abstract][Full Text] [Related]
9. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
Gracies JM; Jech R; Valkovic P; Marque P; Vecchio M; Denes Z; Vilain C; Delafont B; Picaut P
Brain Commun; 2021; 3(1):fcaa201. PubMed ID: 33543139
[TBL] [Abstract][Full Text] [Related]
10. Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy.
Ro T; Ota T; Saito T; Oikawa O
J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104481. PubMed ID: 31699575
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial.
Hokazono A; Etoh S; Jonoshita Y; Kawahira K; Shimodozono M
J Hand Ther; 2022; 35(4):507-515. PubMed ID: 33820711
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Hemiparesis in Adults with Lower Limb Spasticity Previously Treated With Other Botulinum Toxins: A Secondary Analysis of a Randomized Controlled Trial.
Esquenazi A; Stoquart G; Hedera P; Jacinto LJ; Dimanico U; Constant-Boyer F; Brashear A; Grandoulier AS; Vilain C; Picaut P; Gracies JM
PM R; 2020 Sep; 12(9):853-860. PubMed ID: 32108436
[TBL] [Abstract][Full Text] [Related]
13. Effect on Passive Range of Motion and Functional Correlates After a Long-Term Lower Limb Self-Stretch Program in Patients With Chronic Spastic Paresis.
Pradines M; Baude M; Marciniak C; Francisco G; Gracies JM; Hutin E; Bayle N
PM R; 2018 Oct; 10(10):1020-1031. PubMed ID: 29505896
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury.
Esquenazi A; Brashear A; Deltombe T; Rudzinska-Bar M; Krawczyk M; Skoromets A; O'Dell MW; Grandoulier AS; Vilain C; Picaut P; Gracies JM
PM R; 2021 May; 13(5):488-495. PubMed ID: 32741133
[TBL] [Abstract][Full Text] [Related]
15. Coefficients of impairment in deforming spastic paresis.
Gracies JM
Ann Phys Rehabil Med; 2015 Jun; 58(3):173-8. PubMed ID: 26027752
[TBL] [Abstract][Full Text] [Related]
16. Effects of repetitive peripheral magnetic stimulation on upper-limb spasticity and impairment in patients with spastic hemiparesis: a randomized, double-blind, sham-controlled study.
Krewer C; Hartl S; Müller F; Koenig E
Arch Phys Med Rehabil; 2014 Jun; 95(6):1039-47. PubMed ID: 24561057
[TBL] [Abstract][Full Text] [Related]
17. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
Hurvitz EA; Conti GE; Brown SH
Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115
[TBL] [Abstract][Full Text] [Related]
18. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
[TBL] [Abstract][Full Text] [Related]
19. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A for upper limb spasticity.
Kwakkel G; Meskers CG
Lancet Neurol; 2015 Oct; 14(10):969-71. PubMed ID: 26318835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
